top of page
The INVESTED Trial is designed to determine which of two formulations of influenza vaccine, the standard dose or an investigational higher dose, is more effective in reducing deaths and heart- or lung-related admissions to the hospital.
Influenza and Heart Disease

Influenza "flu" can lead to complications like hospitalizations and/or death, particularly in individuals with heart disease. In fact, influenza-related death is more common in people with heart disease than any other chronic health condition. 

Trial News
1/31/19 INVESTED 2018-19 enrollment season ended with a total of 5386 participants enrolled!
9/24/18 First new participant enrolled for the 2018-19 season!
5/22/18 INVESTED Trial Design Paper published in American Heart Journal  

bottom of page